B. Nardelli et al., ORAL-ADMINISTRATION OF AN ANTIGENIC SYNTHETIC LIPOPEPTIDE (MAP-P3C) EVOKES SALIVARY ANTIBODIES AND SYSTEMIC HUMORAL AND CELLULAR-RESPONSES, Vaccine, 12(14), 1994, pp. 1335-1339
Parenteral immunization with a tetravalent multiple antigen peptide (M
AP) containing a gp120 sequence coupled to a synthetic lipophilic moie
ty (MAP-P3C) has been previously found to produce systemic antibody an
d cellular responses in mice. This study demonstrates that oral admini
stration of MAP-P3C induced IgA antibodies in mucosal secretions and p
rotein-specific IgG in the sera of the immunized mice. Moreover, intra
gastric delivery of MAP-P3C generated systemic T-lymphocyte stimulatio
n and specific cytotoxic T-lymphocyte (CTL) activity. The CTL response
was eliminated by treatment with CD8-specific antibody plus complemen
t and was MHC class I-restricted. Therefore, presentation of lipid-lin
ked synthetic peptides to the intestinal mucosal surface is effective
in initiating humoral and cellular immunity both at mucosal sites and
systemically.